Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion type Assertion NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_head.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion wasGeneratedBy ECO_0000203 NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_provenance.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion wasDerivedFrom befree-2016 NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_provenance.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion SIO_000772 20669327 NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_provenance.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion evidence source_evidence_literature NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_provenance.
- NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_assertion description "[Mutations in three other genes, PLA2G6 (PARK14), FBXO7 (PARK15), and Spatacsin (SPG11) also produce clinical similar phenotypes in that they presented with rapidly progressive parkinsonism, initially responsive to Levodopa treatment but later, developed additional features including cognitive decline and loss of Levodopa responsiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829451.RA63kVUVPpHHS5IRe_sGMQC-WYb-TBo-ajAaYhaSyYUl0130_provenance.